China OKs Pfizer COVID drug
Subscribe to keep reading.
Sign up to stay briefed on what the Chinese government is doing, thinking, and saying.
Already a subscriber? Log in.
On Friday, surprising news emerged from China's pharmaceutical regulator (NMPA):
Pfizer's COVID-19 treatment drug – Paxlovid – has received conditional approval to register in China.
It's the first oral pill specifically developed for the disease to be cleared by regulators.
Business wheels are al...